NO20055694L - Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav - Google Patents
Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater deravInfo
- Publication number
- NO20055694L NO20055694L NO20055694A NO20055694A NO20055694L NO 20055694 L NO20055694 L NO 20055694L NO 20055694 A NO20055694 A NO 20055694A NO 20055694 A NO20055694 A NO 20055694A NO 20055694 L NO20055694 L NO 20055694L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- acetonitrile
- preparation
- pyran
- tetrahydro
- Prior art date
Links
- NUTZEIABCUGDLR-UHFFFAOYSA-N 2-(4-hydroxy-6-oxooxan-2-yl)acetonitrile Chemical compound OC1CC(CC#N)OC(=O)C1 NUTZEIABCUGDLR-UHFFFAOYSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 229960005370 atorvastatin Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03101227 | 2003-05-02 | ||
PCT/NL2004/000284 WO2004096788A1 (en) | 2003-05-02 | 2004-04-28 | Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055694D0 NO20055694D0 (no) | 2005-12-01 |
NO20055694L true NO20055694L (no) | 2006-02-02 |
Family
ID=33395971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055694A NO20055694L (no) | 2003-05-02 | 2005-12-01 | Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav |
Country Status (24)
Country | Link |
---|---|
US (1) | US7423162B2 (ru) |
EP (1) | EP1620423B1 (ru) |
JP (1) | JP2006525323A (ru) |
KR (1) | KR20060011984A (ru) |
CN (2) | CN101775000B (ru) |
AT (1) | ATE386734T1 (ru) |
AU (1) | AU2004234308A1 (ru) |
BR (1) | BRPI0409866A (ru) |
CA (1) | CA2524457A1 (ru) |
CO (1) | CO5700715A2 (ru) |
CY (1) | CY1113498T1 (ru) |
DE (1) | DE602004011921T2 (ru) |
DK (1) | DK1620423T3 (ru) |
EA (1) | EA010100B1 (ru) |
ES (1) | ES2300769T3 (ru) |
IL (1) | IL171539A (ru) |
IS (1) | IS8159A (ru) |
NO (1) | NO20055694L (ru) |
NZ (1) | NZ543294A (ru) |
PL (1) | PL1620423T3 (ru) |
SI (1) | SI1620423T1 (ru) |
UA (1) | UA83662C2 (ru) |
WO (1) | WO2004096788A1 (ru) |
ZA (1) | ZA200508862B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1648866A1 (en) | 2003-07-25 | 2006-04-26 | Avecia Pharmaceuticals Limited | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
US7701550B2 (en) | 2004-08-19 | 2010-04-20 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
DE102005022284A1 (de) * | 2005-05-13 | 2006-11-23 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen |
US8047545B2 (en) * | 2007-11-07 | 2011-11-01 | Douglas Press, Inc. | Lottery-type game with rollover feature |
JP5731826B2 (ja) * | 2008-01-23 | 2015-06-10 | レツク・フアーマシユーテイカルズ・デー・デー | ((2s,4r)−4,6−ジヒドロキシテトラヒドロ−2h−ピラン−2−イル)メチルカルボキシラート及び2−デオキシリボース−5−リン酸アルドラーゼを使用の製造方法 |
SI2614057T1 (sl) * | 2010-09-09 | 2016-03-31 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Soli estrov 7-amino-3,5-dihidroksi heptanojske kisline |
US20130178636A1 (en) * | 2010-09-16 | 2013-07-11 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Esters of hexanoic acids as intermediates for the preparation of atorvastatin |
CN105669637A (zh) * | 2014-11-21 | 2016-06-15 | 南京博优康远生物医药科技有限公司 | 一种3,5,6-取代己酸酯衍生物的制备方法 |
CN112501223B (zh) * | 2020-11-23 | 2022-08-12 | 江苏阿尔法药业股份有限公司 | 制备2-((2r,4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法 |
CN116102482A (zh) * | 2022-08-17 | 2023-05-12 | 重庆普佑生物医药有限公司 | 一种阿托伐他汀钙的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5003080A (en) | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
US5097045A (en) * | 1989-02-01 | 1992-03-17 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
NL1015744C2 (nl) * | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
JP2006512086A (ja) * | 2002-09-20 | 2006-04-13 | ダイヴァーサ コーポレイション | スタチンおよびスタチン中間体の合成のための酵素化学的方法 |
-
2004
- 2004-04-28 SI SI200430673T patent/SI1620423T1/sl unknown
- 2004-04-28 DK DK04730128T patent/DK1620423T3/da active
- 2004-04-28 PL PL04730128T patent/PL1620423T3/pl unknown
- 2004-04-28 EA EA200501734A patent/EA010100B1/ru not_active IP Right Cessation
- 2004-04-28 NZ NZ543294A patent/NZ543294A/en unknown
- 2004-04-28 JP JP2006507876A patent/JP2006525323A/ja not_active Withdrawn
- 2004-04-28 CN CN201010111364.9A patent/CN101775000B/zh not_active Expired - Fee Related
- 2004-04-28 EP EP04730128A patent/EP1620423B1/en not_active Expired - Lifetime
- 2004-04-28 CA CA002524457A patent/CA2524457A1/en not_active Abandoned
- 2004-04-28 AU AU2004234308A patent/AU2004234308A1/en not_active Abandoned
- 2004-04-28 AT AT04730128T patent/ATE386734T1/de active
- 2004-04-28 KR KR1020057020818A patent/KR20060011984A/ko not_active Application Discontinuation
- 2004-04-28 BR BRPI0409866-8A patent/BRPI0409866A/pt not_active IP Right Cessation
- 2004-04-28 CN CN2004800117927A patent/CN1780826B/zh not_active Expired - Fee Related
- 2004-04-28 WO PCT/NL2004/000284 patent/WO2004096788A1/en active IP Right Grant
- 2004-04-28 DE DE602004011921T patent/DE602004011921T2/de not_active Expired - Lifetime
- 2004-04-28 UA UAA200511372A patent/UA83662C2/ru unknown
- 2004-04-28 US US10/554,294 patent/US7423162B2/en not_active Expired - Fee Related
- 2004-04-28 ES ES04730128T patent/ES2300769T3/es not_active Expired - Lifetime
-
2005
- 2005-10-23 IL IL171539A patent/IL171539A/en active IP Right Grant
- 2005-11-01 ZA ZA200508862A patent/ZA200508862B/xx unknown
- 2005-11-02 CO CO05111845A patent/CO5700715A2/es not_active Application Discontinuation
- 2005-11-30 IS IS8159A patent/IS8159A/is unknown
- 2005-12-01 NO NO20055694A patent/NO20055694L/no not_active Application Discontinuation
-
2008
- 2008-05-13 CY CY20081100505T patent/CY1113498T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0409866A (pt) | 2006-05-16 |
CA2524457A1 (en) | 2004-11-11 |
PL1620423T3 (pl) | 2008-07-31 |
CY1113498T1 (el) | 2016-06-22 |
CN101775000A (zh) | 2010-07-14 |
EA010100B1 (ru) | 2008-06-30 |
DE602004011921D1 (de) | 2008-04-03 |
CN1780826B (zh) | 2010-05-26 |
EP1620423A1 (en) | 2006-02-01 |
CN101775000B (zh) | 2014-09-24 |
NO20055694D0 (no) | 2005-12-01 |
ATE386734T1 (de) | 2008-03-15 |
JP2006525323A (ja) | 2006-11-09 |
IL171539A (en) | 2011-03-31 |
AU2004234308A1 (en) | 2004-11-11 |
US7423162B2 (en) | 2008-09-09 |
NZ543294A (en) | 2008-05-30 |
WO2004096788A1 (en) | 2004-11-11 |
DE602004011921T2 (de) | 2009-02-19 |
CO5700715A2 (es) | 2006-11-30 |
DK1620423T3 (da) | 2008-05-26 |
SI1620423T1 (sl) | 2008-06-30 |
ES2300769T3 (es) | 2008-06-16 |
EP1620423B1 (en) | 2008-02-20 |
ZA200508862B (en) | 2007-02-28 |
US20060258733A1 (en) | 2006-11-16 |
UA83662C2 (ru) | 2008-08-11 |
CN1780826A (zh) | 2006-05-31 |
EA200501734A1 (ru) | 2006-04-28 |
IS8159A (is) | 2005-11-30 |
KR20060011984A (ko) | 2006-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055694L (no) | Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav | |
NO20100062L (no) | Overflatereagert kalsiumkarbonat i kombinasjon med hydrofob adsorbent for vannbehandling | |
PL377838A1 (pl) | Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy | |
MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
EA201070001A1 (ru) | Водная композиция, содержащая соль, способ её получения и применения | |
NO20083411L (no) | Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling | |
WO2006012395A3 (en) | Peptidase inhibitors | |
BR0308385A (pt) | Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso | |
PL1751093T3 (pl) | Podstawione pochodne kwasu cykloheksylooctowego | |
MX2009005863A (es) | Procedimiento para la preparacion de compuestos heterociclicos sustituidos por fluorometilo. | |
NO20050270L (no) | Nye forbindelser, deres anvendelse og fremstilling | |
NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
TW200719889A (en) | Amino acid derivatives | |
NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
SE0200843D0 (sv) | Chemical compounds | |
NO20082005L (no) | Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon | |
KR101632545B1 (ko) | 황산 환원균의 선택적 제균방법, 상기 방법에 의해 황산 환원균의 증식을 억제하는 석고 조성물, 석고계 고화재 및 석고계 건재 | |
NO20064410L (no) | Fremgangsmate for fremstilling av tryptaseinhibitorer | |
RU2006110716A (ru) | Способ получения полиметилентетразолов | |
TH79415B (th) | กระบวนการสำหรับการเตรียมไพริมิดีนที่ถูกแทนที่ | |
IL158530A0 (en) | Method for producing 1,3-disubstituted 2-nitroguanidines | |
TH79415A (th) | กระบวนการสำหรับการเตรียมไพริมิดีนที่ถูกแทนที่ | |
TW200616893A (en) | Method for manufacturing aluminum salt solution, aluminum salt solution, aluminum salt, water purifying apparatus using the same, and articles manufactured by using the same | |
WO2007016209A3 (en) | Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process | |
MXPA04004537A (es) | Derivados de gabusectina, metodo para produccion de los mismos y uso de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |